| Primary |
| Type 2 Diabetes Mellitus |
28.4% |
| Drug Use For Unknown Indication |
16.9% |
| Product Used For Unknown Indication |
13.0% |
| Diabetes Mellitus |
11.5% |
| Type 1 Diabetes Mellitus |
10.3% |
| Insulin-requiring Type 2 Diabetes Mellitus |
5.0% |
| Hypertension |
3.8% |
| Insulin-requiring Type Ii Diabetes Mellitus |
2.7% |
| Atrial Fibrillation |
1.5% |
| Gestational Diabetes |
1.1% |
| Diabetes Mellitus Non-insulin-dependent |
0.8% |
| Erythrodermic Psoriasis |
0.8% |
| Gastrointestinal Disorder |
0.8% |
| Insomnia |
0.8% |
| Urinary Tract Infection |
0.8% |
| Cardiac Failure |
0.4% |
| Chronic Obstructive Pulmonary Disease |
0.4% |
| Depression |
0.4% |
| Diabetes Mellitus Insulin-dependent |
0.4% |
| Hyperglycaemia |
0.4% |
|
| Urinary Tract Infection |
10.0% |
| Hypoglycaemia |
8.3% |
| Pneumonia |
8.3% |
| Respiration Abnormal |
6.7% |
| Blood Glucose Increased |
5.0% |
| Coronary Artery Disease |
5.0% |
| Headache |
5.0% |
| Hypothermia |
5.0% |
| Incorrect Dose Administered |
5.0% |
| Malaise |
5.0% |
| Pulmonary Oedema |
5.0% |
| Vomiting |
5.0% |
| Cardiac Failure Chronic |
3.3% |
| Convulsion |
3.3% |
| Death |
3.3% |
| Fall |
3.3% |
| Generalised Erythema |
3.3% |
| Hypoglycaemic Coma |
3.3% |
| Hypoglycaemic Seizure |
3.3% |
| Injection Site Pain |
3.3% |
|
| Secondary |
| Diabetes Mellitus |
18.0% |
| Type 2 Diabetes Mellitus |
17.1% |
| Type 1 Diabetes Mellitus |
16.6% |
| Diabetes Mellitus Insulin-dependent |
8.3% |
| Drug Use For Unknown Indication |
7.4% |
| Insulin-requiring Type 2 Diabetes Mellitus |
6.5% |
| Product Used For Unknown Indication |
5.5% |
| Gestational Diabetes |
3.7% |
| Hypertension |
3.7% |
| Erythrodermic Psoriasis |
1.8% |
| Prophylaxis |
1.8% |
| Thrombosis Prophylaxis |
1.8% |
| Antiplatelet Therapy |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Insulin-requiring Type Ii Diabetes Mellitus |
1.4% |
| Liver Disorder |
1.4% |
| Sleep Disorder Therapy |
1.4% |
| Hyperuricaemia |
0.9% |
|
| Hypoglycaemia |
12.0% |
| Influenza Like Illness |
10.0% |
| Intentional Overdose |
8.0% |
| Pneumonia |
8.0% |
| Drug Resistance |
6.0% |
| Tongue Oedema |
6.0% |
| Urinary Tract Infection |
6.0% |
| Diabetes Mellitus Inadequate Control |
4.0% |
| Hypoglycaemic Coma |
4.0% |
| Hypoglycaemic Seizure |
4.0% |
| Injection Site Reaction |
4.0% |
| Loss Of Consciousness |
4.0% |
| Myocardial Infarction |
4.0% |
| Premature Baby |
4.0% |
| Renal Function Test Abnormal |
4.0% |
| Weight Increased |
4.0% |
| Blood Glucose Increased |
2.0% |
| Blood Pressure Decreased |
2.0% |
| Breast Cancer |
2.0% |
| Dyspnoea |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.5% |
| Product Used For Unknown Indication |
21.6% |
| Hypertension |
11.1% |
| Type 2 Diabetes Mellitus |
9.3% |
| Diabetes Mellitus |
7.3% |
| Rheumatoid Arthritis |
3.5% |
| Hypercholesterolaemia |
2.7% |
| Cardiomyopathy |
1.9% |
| Chronic Lymphocytic Leukaemia |
1.9% |
| Central Nervous System Lymphoma |
1.6% |
| Type 1 Diabetes Mellitus |
1.3% |
| Diabetes Mellitus Insulin-dependent |
1.1% |
| Non-small Cell Lung Cancer |
1.1% |
| Psoriatic Arthropathy |
1.1% |
| Angina Pectoris |
0.9% |
| Idiopathic Thrombocytopenic Purpura |
0.9% |
| Asthma |
0.8% |
| Blood Pressure |
0.8% |
| Cardiac Failure Chronic |
0.8% |
| Coronary Artery Disease |
0.8% |
|
| Hypertension |
8.6% |
| Pneumocystis Jiroveci Pneumonia |
8.6% |
| Renal Failure |
8.6% |
| Vitamin D Decreased |
8.6% |
| Vomiting |
8.6% |
| Squamous Cell Carcinoma |
5.7% |
| Weight Decreased |
5.7% |
| Blood Potassium Increased |
4.3% |
| Nausea |
4.3% |
| Renal Failure Acute |
4.3% |
| Staphylococcal Infection |
4.3% |
| Swelling |
4.3% |
| Syncope |
4.3% |
| Basal Cell Carcinoma |
2.9% |
| Death |
2.9% |
| Diabetic Ketoacidosis |
2.9% |
| Hip Fracture |
2.9% |
| Hyperkalaemia |
2.9% |
| Hypoglycaemia |
2.9% |
| Pancreatitis |
2.9% |
|
| Interacting |
| Hypertension |
21.4% |
| Multiple Sclerosis |
21.4% |
| Diabetes Mellitus |
14.3% |
| Type 2 Diabetes Mellitus |
14.3% |
| Diabetes Insipidus |
7.1% |
| Podagra |
7.1% |
| Renal Failure |
7.1% |
| Renal Failure Chronic |
7.1% |
|
| Jaundice |
50.0% |
| Renal Failure |
50.0% |
|
